Brief: Sales Of Intervacc's Strangles Vaccine To Begin In Q1 2022

Intervacc AB

14/12/2021 15:43

Dec 14 (Reuters) - Intervacc AB  IVACC.ST :
    * SALES OF COMPANY'S STRANGLES VACCINE STRANGVAC ARE PLANNED
TO
BEGIN IN Q1 OF 2022

Source text for Eikon:  ID:nWkr3vjTK 
Further company coverage:  IVACC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))